Scotts Miracle-Gro (NYSE: SMG) reported Q1 EPS of ($0.89), $0.35 better than the analyst estimate of ($1.24). Revenue for the quarter came in at $416.8 million versus the consensus estimate of $392.29 million.

Fiscal 2025 Outlook

The Company reaffirms the non-GAAP fiscal 2025 guidance for key elements of non-GAAP adjusted EBITDA provided last quarter and lowers expected interest expense. Highlights include:

U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales)
Hawthorne net sales mid-single digit decrease
Non-GAAP adjusted gross margin of approximately 30 percent
Non-GAAP adjusted EBITDA of $570 million to $590 million
Interest expense $15 million to $20 million lower than prior year, previously a $10 million decrease

For earnings history and earnings-related data on Scotts Miracle-Gro (SMG) click here.